Skip to content
Subscriber Only
Business
Prognosis

Astra Vaccine Woes Grow as Regulators Try to Ease Clot Fears

  • Shot once seen as frontrunner now faces halts globally
  • Company says no evidence vaccine increases blood-clot risk
Video player cover image
WATCH: Ireland and northern Italy on Sunday joined a growing list of about a dozen regions in Europe moving to suspend AstraZeneca Plc’s Covid-19 vaccine over concerns about possible side effects from two batches.(Source: Bloomberg)
Updated on

We're tracking the latest on the coronavirus outbreak and the global response. Sign up here for our daily newsletter on what you need to know.

AstraZeneca Plc’s vaccine for Covid-19, once expected to be a mainstay of protection for much of the world, remains shrouded in controversy as more countries limit its use even as scientists warn of the need for governments to tread carefully.